Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam, Regulus, CHOP, and More


Title: microRNA Affinity Assay and Uses Thereof

Patent Number: 8,846,350

Filed: Oct. 18, 2010

Lead Inventor: Simon Spivack, Albert Einstein College of Medicine

Title: sVEGFR-2 and Its Role in Lymphangiogenesis Modulation

Patent Number: 8,846,386

Filed: Dec. 18, 2008

Lead Inventor: Jayakrishna Ambati, University of Kentucky

Title: Pharmaceutical Composition for Treating Cancer

Patent Number: 8,846,630

Filed: Nov. 1, 2010

Lead Inventor: Misun Won, Korea Research Institute of Bioscience and Biotechnology

Title: microRNA Compositions and Methods

Patent Number: 8,846,631

Filed: Nov. 1, 2010

Lead Inventor: Eric Marcusson, Regulus Therapeutics

Title: Nucleic Acids for Targeting Multiple Regions of the HCV Genome

Patent Number: 8,846,632

Filed: Nov. 1, 2010

Inventor: Linda Couto, Children's Hospital of Philadelphia

Title: RNA Interference-mediated Inhibition of Gene Expression using Chemically Modified Short Interfering Nucleic Acid

Patent Number: 8,846,894

Filed: Feb. 16, 2007

Inventor: James McSwiggen, Sirna Therapeutics (Alnylam Pharmaceuticals)

Title: Double-stranded RNA Molecules with Stability in Mammalian Body Fluid, Preparation and Application Thereof

Patent Number: 8,846,895

Filed: March 29, 2011

Inventor: Quan Du, Biomics Biotechnologies